Fortive

US · FTV #1059 by market cap Listed 2016

56.52 -1.37 -2.37%

Live - 5344 symbols - heartbeat 80s ago · 2026-10-07 19:54

After-hours 56.52 0.00%

Market cap: 17.07B
P/E (TTM): 33.44
P/B: 2.82
EPS: 1.73
Div yield: 0.42%
52W pos: 52%

Reader sentiment Are you bullish or bearish on FTV?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 3.08, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +1.92% YoY

Margins

Gross margin: 63.50%
Operating margin: 17.32%
Net margin: 13.93%

Key ratios & quality

Enterprise value: 19.93B
Altman Z-Score: 3.08

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	3.80B	4.56B	4.63B	5.25B	5.83B	3.91B	4.08B	4.16B
Gross profit	2.19B	2.48B	2.61B	3.01B	3.36B	2.48B	2.62B	2.64B
Selling & admin expenses	1.26B	1.72B	1.75B	1.84B	1.96B	1.67B	1.65B	1.66B
Research & development	278.10M	320.30M	320.70M	354.80M	401.50M	237.00M	251.30M	259.20M
Operating profit	645.30M	443.90M	539.40M	812.80M	1.01B	574.00M	716.30M	720.20M
Pretax profit	565.80M	336.70M	1.51B	677.50M	873.50M	433.10M	506.30M	602.20M
Tax	75.60M	68.60M	55.50M	63.30M	118.30M	24.70M	23.80M	69.50M
Net profit	2.91B	738.90M	1.61B	608.40M	755.20M	865.80M	832.90M	579.20M
Basic EPS	8	2	5	2	2	2	2	2
Diluted EPS	8.21	1.97	4.49	1.63	2.10	2.43	2.36	1.73

Line item	2025-03	2025-06	2025-09	2025-12	2026-04	2026-07
Revenue	993.10M	1.02B	1.03B	1.12B	1.07B	1.10B
Gross profit	637.50M	645.50M	649.20M	708.90M	675.50M	695.30M
Selling & admin expenses	408.20M	408.50M	427.60M	417.40M	417.30M	417.90M
Research & development	64.00M	67.20M	62.00M	66.00M	66.50M	67.50M
Operating profit	165.30M	169.80M	159.60M	225.50M	191.70M	209.90M
Pretax profit	133.70M	139.60M	135.00M	193.90M	163.60M	179.50M
Tax	21.10M	28.00M	18.00M	2.40M	27.20M	22.20M
Net profit	171.90M	166.60M	55.00M	185.70M	136.40M	157.30M
Basic EPS	1	0	0	1	0	1
Diluted EPS	0.50	0.49	0.16	0.58	0.44	0.51

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	3.17B	3.69B	4.45B	2.51B	2.48B	3.67B	2.59B	1.61B
Cash & ST investments	1.18B	1.21B	2.94B	819.30M	709.20M	1.89B	813.30M	375.50M
Inventory	574.50M	416.20M	455.50M	512.70M	536.70M	536.90M	269.80M	291.80M
Total assets	12.91B	17.44B	16.05B	16.47B	15.89B	16.91B	17.02B	11.74B
Total current liabilities	2.19B	3.47B	2.86B	3.71B	2.73B	1.79B	2.24B	2.25B
Short-term debt	455.60M	1.54B	1.45B	2.20B	1.04B	37.60M	376.20M	926.50M
Long-term debt	2.97B	4.83B	2.83B	1.81B	2.25B	3.65B	3.33B	2.31B
Total liabilities	6,292,700,000.00	10,038,800,000.00	7,078,800,000.00	6,948,500,000.00	6,202,000,000.00	6,586,500,000.00	6,820,500,000.00	5,276,600,000.00
Total equity	6.61B	7.40B	8.97B	9.52B	9.69B	10.33B	10.20B	6.46B
Retained earnings	3.55B	4.13B	5.55B	6.02B	6.74B	7.51B	8.23B	5.43B

Line item	2025-03	2025-06	2025-09	2025-12	2026-04	2026-07
Total current assets	2.70B	3.68B	1.73B	1.61B	1.55B	1.60B
Cash & ST investments	892.10M	1.83B	430.80M	375.50M	356.10M	374.20M
Inventory	568.00M	610.40M	310.60M	291.80M	305.50M	310.80M
Total assets	17.14B	18.24B	11.89B	11.74B	11.58B	11.62B
Total current liabilities	2.73B	3.75B	2.47B	2.25B	2.19B	1.29B
Short-term debt	933.80M	1.91B	1.19B	926.50M	899.80M	--
Long-term debt	2.93B	2.91B	2.12B	2.31B	2.59B	3.51B
Total liabilities	6,893,700,000.00	7,855,000,000.00	5,375,200,000.00	5,276,600,000.00	5,492,700,000.00	5,545,600,000.00
Total equity	10.24B	10.39B	6.51B	6.46B	6.09B	6.07B
Retained earnings	8.37B	8.51B	5.26B	5.43B	5.55B	5.69B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	1.34B	1.27B	1.44B	961.10M	1.30B	1.35B	1.53B	1.08B
Depreciation & amortization	174.20M	341.50M	384.00M	395.50M	465.60M	426.20M	430.90M	437.60M
Free cash flow	1.27B	1.20B	1.36B	911.10M	1.21B	1.35B	1.53B	1.08B
Dividends paid	-131.50M	-162.80M	-163.40M	-132.20M	-99.50M	-102.00M	-111.20M	-92.20M
Stock buybacks / issuance	--	--	0	0	-442.90M	-272.90M	-889.60M	-1.61B
Ending cash balance	1.18B	1.21B	1.82B	819.30M	709.20M	1.89B	813.30M	375.50M

Line item	2025-03	2025-06	2025-09	2025-12	2026-04	2026-07
Operating cash flow	241.70M	311.20M	164.40M	365.90M	234.80M	286.20M
Depreciation & amortization	108.00M	109.20M	109.10M	111.30M	113.60M	113.50M
Free cash flow	241.70M	311.20M	89.70M	440.60M	234.80M	286.20M
Dividends paid	-27.20M	-27.00M	-19.20M	-18.80M	-18.40M	0
Stock buybacks / issuance	-202.60M	-135.00M	-1.01B	-265.00M	-500.20M	-200.10M
Ending cash balance	892.10M	1.83B	430.80M	375.50M	356.10M	392.30M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	55.44	9.58	18.89	6.21	7.87	8.66	8.12	6.96
ROA %	24.60	4.42	9.22	3.53	4.67	5.28	4.91	4.03
ROIC %	32.32	6.73	12.35	4.94	6.28	7.15	6.84	5.76
5-year avg ROE %	28.70	27.21	27.67	24.47	19.60	10.25	9.95	7.57
EBIT margin %	18.22	14.19	35.74	14.86	16.68	18.37	18.01	17.38
FCF / sales %	19.09	15.83	29.37	17.34	20.73	20.54	22.57	26.04
Current ratio	1.45	1.06	1.55	0.68	0.91	2.05	1.16	0.71
Quick ratio	1.08	0.60	1.31	0.47	0.61	1.59	0.66	0.47
Debt / assets	26.58	37.28	27.61	25.16	21.53	22.53	21.79	28.17
LT debt / equity	45.10	67.15	33.29	20.47	24.61	36.56	32.69	36.88
Interest coverage	12.12	6.33	11.15	7.56	9.89	9.02	7.35	6.00
Revenue CAGR (3Y) %	-14.96	-5.33	-6.97	11.41	8.48	-5.48	-8.08	-10.62
Net income CAGR (3Y) %	49.97	-5.38	15.59	-40.67	0.73	-18.74	11.04	-8.46
FCF CAGR (3Y) %	12.76	5.24	8.51	-10.59	0.29	-0.18	18.78	-3.55

Line item	2025-03	2025-06	2025-09	2025-12	2026-04	2026-07
ROE %	7.70	7.36	7.06	6.96	6.66	6.50
ROA %	4.60	4.33	4.11	4.03	3.79	3.58
ROIC %	6.23	6.00	4.97	5.76	5.49	4.68
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	17.44	16.83	17.78	17.38	17.76	18.29
FCF / sales %	22.50	22.54	17.38	26.04	25.41	24.36
Current ratio	0.99	0.98	0.70	0.71	0.71	1.24
Quick ratio	0.67	0.73	0.43	0.47	0.46	0.80
Debt / assets	22.54	26.38	27.82	28.17	30.12	30.21
LT debt / equity	28.61	28.00	32.55	36.88	42.57	57.90
Interest coverage	7.65	7.71	--	6.00	6.26	--
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Intelligent Operating Solutions is the largest reported line at 69.13% of revenue, across 2 reported segments.
Advanced Healthcare Solutions follows at 30.87%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Intelligent Operating Solutions69.13%

Advanced Healthcare Solutions30.87%

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.